changes in metabolomic profiles.
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Residing in Tehran in the study period Age: 18-35 years old Participants should be healthy( this criteria is validated by the physician's observations
Exclusion criteria
Exclusion criteria: Having the history of cardiovascular or respiratory or metabolic diseases Smoking Alcohol consumption Consuming the drugs that affect the metabolism
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Systolic Blood Pressure( SBP) & Diastolic Blood Pressure(DBP). Timepoint: Before blood sampling( before & after each exposure session). Method of measurement: Using a Beurer blood pressure monitor. | — |
Secondary
| Measure | Time frame |
|---|---|
| Metabolites. Timepoint: 2 weeks after the end of the exposure session. Method of measurement: Using LC-MS/MS.;Metabolite intensity. Timepoint: 2 weeks after the end of the exposure session. Method of measurement: Using LC-MS/MS.;Total number of metabolites in participants. Timepoint: 2 weeks after the end of the exposure session. Method of measurement: Using LC-MS/MS. | — |
Countries
Iran (Islamic Republic of)
Contacts
Tehran University of Medical Sciences